DHA

(redirected from Dihydroartemisinin)
Also found in: Medical, Wikipedia.
AcronymDefinition
DHADocosahexaenoic Acid
DHADepartment of Home Affairs
DHADubai Health Authority (previously known as DOHMS)
DHADefence Housing Authority
DHADihydroxyacetone
DHADepartment of Humanitarian Affairs (United Nations)
DHADoctor of Health Administration
DHADirectory Harvest Attack
DHADallas Housing Authority
DHADihydroartemisinin (antimalarial drug)
DHADivision of Hearings and Appeals (Wisconsin)
DHADehydroascorbate
DHACommonwealth Department of Health and Ageing (Australia)
DHADisaster Housing Assistance (FEMA)
DHADetroit Hockey Association (Detroit, MI)
DHADirect Hardware Access
DHADetainee Holding Area
DHADescend, Heartless Angel (Kingdom Hearts game)
DHADoctor of Healthcare Administration
DHADanube Hydro Austria
DHADirect Historic Approach (archaeology)
DhADe-Hydroabietic Acid
DHADependent Housing Area
DHADesign Hazard Analysis
DHADirect Humanitarian Aid
DHADeparture Holding Area
DHADhahran, Saudi Arabia - Dhahran International (Airport Code)
DHADigital Headed Assembly
DHADepartment of Hearings and Appeals
DHADirections for Handling and Administration (clinical trials)
DHADialogues d'Histoire Ancienne (French: Dialogues of Ancient History)
DHADistri Haut Anjou (French firewood business)
DHADavid Higham Associates (UK)
References in periodicals archive ?
Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity.
13-16 h]]) from highly synchronous cultures were exposed to 700 nmol/L dihydroartemisinin or 0.
The blood concentrations of artesunate and dihydroartemisinin may have been 20% lower than ideal (as predicted by a pharmacokinetic model), but this finding cannot explain why the parasite density remained >200,000/pL for several days.
2002), and the artemisinin derivative dihydroartemisinin targets human metastatic tumor cells (Cabello et al.
Antifertility Activity Of Dihydroartemisinin In Male Albino Rats.
At day 6 of hospitalization, artesunate and clindamycin were discontinued, and oral treatment with dihydroartemisinin (40 mg/tablet)/piperaquine (320 mg/tablet) was administered through a nasogastric tube for 3 days (4 tablets/day the first day, then 2 tablets/day).
579), but a significant association was found for dihydroartemisinin (p = 0.
The availability of counterfeit artesunate and counterfeit dihydroartemisinin has also been reported in Cameroon and Tanzania (12).
Deoxyqinghaosu, dihydroartemisinin, 3-desoxy- and arteannuic acid were proved to be present only in A.
Because dihydroartemisinin has a short half-life (26), prolonged hemolysis after stopping treatment with IV artesunate and the recurring hemolysis in 2 patients suggest that a direct hemolytic effect of the drug is unlikely, although contaminants may have a longer half-life.
The studies were designed to compare the safety and efficacy of the combination of dihydroartemisinin and piperaquine (DHA/PQP) to the ACTs artemether/lumefantrine (in Africa) and artesunate+mefloquine (in Asia).
Artesunate is an antimalaria agent and a hemi-succinate derivative of dihydroartemisinin.